Journal of Personalized Medicine | |
Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study | |
Michael Gatusky1  Alanna K. Rahm1  Andrew Brangan1  Laney K. Jones1  Gemme Campbell-Salome1  Nicole Walters1  Ilene G. Ladd1  Amy C. Sturm1  Samuel S. Gidding1  Catherine D. Ahmed2  Mary P. McGowan2  Amanda Sheldon2  | |
[1] Genomic Medicine Institute, Geisinger, Danville, PA 17822, USA;The FH Foundation, Pasadena, CA 91101, USA; | |
关键词: familial hypercholesterolemia; identification; implementation outcomes; cascade screening; cascade testing; chatbots; | |
DOI : 10.3390/jpm11060587 | |
来源: DOAJ |
【 摘 要 】
Guided by the Conceptual Model of Implementation Research, we explored the acceptability, appropriateness, and feasibility of: (1) automated screening approaches utilizing existing health data to identify those who require subsequent diagnostic evaluation for familial hypercholesterolemia (FH) and (2) family communication methods including chatbots and direct contact to communicate information about inherited risk for FH. Focus groups were conducted with 22 individuals with FH (2 groups) and 20 clinicians (3 groups). These were recorded, transcribed, and analyzed using deductive (coded to implementation outcomes) and inductive (themes based on focus group discussions) methods. All stakeholders described these initiatives as: (1) acceptable and appropriate to identify individuals with FH and communicate risk with at-risk relatives; and (2) feasible to implement in current practice. Stakeholders cited current initiatives, outside of FH (e.g., pneumonia protocols, colon cancer and breast cancer screenings), that gave them confidence for successful implementation. Stakeholders described perceived obstacles, such as nonfamiliarity with FH, that could hinder implementation and potential solutions to improve systematic uptake of these initiatives. Automated health data screening, chatbots, and direct contact approaches may be useful for patients and clinicians to improve FH diagnosis and cascade screening.
【 授权许可】
Unknown